Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-23

Clinical Trial Update: Therapeutic Instillation of Mistletoe [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for mistletoe extract intravesical therapy in superficial bladder cancer shows the study is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mistletoe extract (Viscum album extract)

Snippet

Sponsor: Abnoba Gmbh | Conditions: Superficial Bladder Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING